“The move comes after Shkreli, its former CEO, was charged on December 17 in federal court with securities fraud related to a hedge fund and another company. Shkreli pleaded not guilty to the charges. Shkreli initially gained notoriety in September when, as the chief executive of Turing Pharmaceuticals, he raised the price of Daraprim— a drug used to treat a dangerous parasitic infection— from $13.50 to $750 per pill. The move generated harsh criticism from prominent politicians, including Hillary Clinton, and spurred a senate investigation into drug pricing.”
http://www.nydailynews.com/news/national/martin-shkreli-company-files-bankruptcy-article-1.2481147
Related posts:
Bitcoin surges 40% after US Senate hearing
China’s Largest Bank Declares War on Alibaba
Meet the Bitcoin Millionaires
Ron Paul: NSA head ‘fudged the figures’
US says Turk offensive in Syria is 'disruptive' to its own open-ended occupation
Social Security Ran $47.8B Deficit in FY 2012; Disabled Workers Hit New Record in December: 8,827,79...
Official: Potential Syria strikes could include long-range bombers
Countries are using devaluation to gain an advantage - and Britain is one of the worst offenders
Swiss solar aircraft returns from cross-US flight
America’s new target shooters: Younger, female and urban
American Citizens: U.S. Border Agents Can Search Your Cellphone
Cyprus lifts all capital controls as banks recover
U.S. ‘influenced British government’s decision to introduce secret courts’
Federal gov't to McDonald’s: You are responsible for your franchisees
The People Making Real Money On Bitcoin